ADMA BIOLOGICS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for the quarter ending 2020-09-30 was $10.64M.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for the quarter ending 2020-03-31 was $88.70M.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for the quarter ending 2019-12-31 was $0.00.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for the quarter ending 2019-06-30 was $48.40M, a 12.69% increase year-over-year.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for fiscal 2020 was $131.20M, a 171.08% increase from fiscal 2019.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for fiscal 2019 was $48.40M.
- ADMA BIOLOGICS, INC. stock issued during period, value, other for fiscal 2011 was $9.64M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2020-12-31 | $131.20M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $10.64M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $88.70M 10-Q · filed 2020-11-05 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $48.40M 10-K · filed 2021-03-25 |
| 2019-06-30 | $48.40M 10-Q · filed 2020-11-05 | |
| 2018-09-30 | -$1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | |
| 2018-06-30 | $42.95M 10-Q · filed 2019-08-08 | |
| 2011-12-31 | $9.64M 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |